Defining the risks of mesenchymal stromal cell therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20735162.
- Also identified by DOI 10.3109/14653249.2010.507330.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Abstract We address the issue of the potential for malignant transformation of cultured mesenchymal stromal cells (MSC) commonly used in clinical cell-therapy protocols and describe the culture conditions under which tumorigenesis is likely to be an extremely uncommon event.
Medical subject headings
- Adult Stem Cells
- Cell Transformation, Neoplastic
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells
- Stromal Cells